Interval Faecal occult blood testing in a colonoscopy based screening programme detects additional pathology

Bampton, P. A.; Sandford, J. J.; Cole, S. R.; Smith, A.; Morcom, J.; Cadd, B.; Young, G. P.
June 2005
Gut;Jun2005, Vol. 54 Issue 6, p803
Academic Journal
Background: Colonoscopic based surveillance is recommended for patients at increased risk of colorectal cancer. The appropriate interval between surveillance colonoscopies remains in debate, as is the "miss rate" for colorectal cancer within such screening programmes. Aims: The main aim of this study was to determine whether a one-off interval faecal occult blood test (FOBT) facilitates the detection of significant neoplasia within a colonoscopic based surveillance programme. Secondary aims were to determine if invitees were interested in participating in interval screening, and to determine whether interval lesions were missed or whether they developed rapidly since the previous colonoscopy Patients: Patients enrolled in a colonoscopic based screening programme due to a personal history cf colorectal neoplasia or a significant family history. Methods: Patients within the screening programme were invited to perform an immunochemical FOBT (Inform). A positive result was followed by colonoscopy; significant neoplasia was defined as colorectal cancer, adenomas either ⩾ 10 mm or with a villous component, high grade dysplasia, or multiplicity (⩾3 adenomas). Participation rates were determined for age, sex, and socioeconomic subgroups. Colonoscopy recall databases were examined to determine the interval between previous colonoscopy and FOST offer, and correlations between lesion characteristics and interval time were determined. Results: A total of 785 of 1641 patients invited (47.8%) completed an Inform kit. A positive result was recorded for 57(7.3%). Fifty two of the 57 test positive patients completed colonoscopy; 14 (1.8% of those completing the FOBT) had a significant neoplastic lesion. These consisted of six colorectal cancers and eight significant adenomas. Conclusions: A one off immunochemical faecal occult blood test within a colonoscopy based surveillance programme had a participation rate of nearly 50% and appeared to detect additional pathology, especially in patients with a past history of colonic neoplasia.


Related Articles


    Background and aim. FOBT detects a high proportion of less advanced colorectal cancers (CRC) in asymptomatic patients. We aimed to assess the effectiveness of FOBT screening on CRC detection in Romania. Methods. We used Hemoccult II to assess the presence of occult blood in stools. This was a...

  • Performance Characteristics and Evaluation of an Automated-Developed and Quantitative, Immunochemical, Fecal Occult Blood Screening Test. Vilkin, Alex; Rozen, Paul; Levi, Zohar; Waked, Amal; Maoz, Eran; Birkenfeld, Shlomo; Niv, Yaron // American Journal of Gastroenterology;Nov2005, Vol. 100 Issue 11, p2519 

    OBJECTIVES: Guaiac fecal occult blood colorectal cancer (CRC) screening tests (FOBT) are faulted for low sensitivity and nonspecificity for human hemoglobin (Hb). Automated-developed, immunochemical, human Hb FOBT (I-FOBT) is specific, eliminates diet restrictions, and Hb quantification allows...

  • Comparison of a guaiac based and an immunochemical faecal occult blood test in screening for colorectal cancer in a general average risk population. Guittet, I.; Bouvier, V.; Mariotte, N.; Vallee, J. P.; Arsène, D.; Boufreux, S.; Tichet, J.; Launoy, G. // Gut;Feb2007, Vol. 56 Issue 2, p210 

    Background: The guaiac faecal occult blood test (G-FOBT) is recommended as a screening test for colorectal cancer but its low sensitivity has prevented its use throughout the world. Methods: We compared the performances of the reference G-FOBT (non-rehydrated Hemoccult II test) and the...

  • Comparison of a guaiac and an immunochemical faecal occult blood test for the detection of colonic lesions according to lesion type and location. Guittet, L.; Bouvier, V.; Mariotte, N.; Vallee, J. P.; Levillain, R.; Tichet, J.; Launoy, G. // British Journal of Cancer;4/21/2009, Vol. 100 Issue 8, p1230 

    We investigated variations in sensitivity of an immunochemical (I-FOBT) and a guaiac (G-FOBT) faecal occult blood test according to type and location of lesions in an average-risk 50- to 74-year-old population. Screening for colorectal cancer by both non-rehydrated Haemoccult II G-FOBT and...

  • Model of estimated rates of colorectal cancer from polyp growth by year of surveillance. Wilson, L. S.; Lightwood, J. // Journal of Medical Screening;Dec2001, Vol. 8 Issue 4, p187 

    OBJECTIVE:Most studies show protective effects of non-steroidal anti-inflamatory drugs (NSAIDs) against polyps and colorectal cancers (CRCs) of up to 50%. Current models are unable to directly estimate changes in effects of chemoprevention on CRCs. The purpose is to develop a model to examine...

  • A prospective clinicopathological and endoscopic evaluation of flat and depressed colorectal lesions in the United Kingdom. Hurlstone, David P.; Cross, Simon S.; Adam, Ian; Shorthouse, Andrew J.; Brown, Steven; Sanders, David S.; Lobo, Alan J. // American Journal of Gastroenterology;Nov2003, Vol. 98 Issue 11, p2543 

    : ObjectivesFlat and depressed colorectal lesions are now reported in Western populations. The malignant potential, anatomical distribution, and other clinicopathological features have not been established in this group. This study aimed to assess prospectively the prevalence,...

  • Screening and Polyp Removal Spur Decline.  // USA Today Magazine;Feb2000, Vol. 128 Issue 2657, p11 

    Reports that a decline in the incidence of colorectal cancer in the United States is due to the screening and removal of precancerous polyps. Correlation between the incidence decline and the increase in screening by colonoscopy; Factors that may have contributed to the declining colorectal cancer.

  • Recommendations for post-polypectomy surveillance in community practice. Ransohoff, David; Yankaskas, Bonnie; Gizlice, Ziya; Gangarosa, Lisa; Ransohoff, David F // Digestive Diseases & Sciences;Sep2011, Vol. 56 Issue 9, p2623 

    Background: After colon cancer screening, large numbers of persons discovered with colon polyps may receive post-polypectomy surveillance with multiple colonoscopy examinations over time. Decisions about surveillance interval are based in part on polyp size, histology, and...

  • Hemoccult tests are insensitive for upper gastrointestinal cancer. Johnson, Sally R.; Newton, Warren P. // Journal of Family Practice;Jul2002, Vol. 51 Issue 7, p601 

    The article presents information about the efficacy of fecal occult blood test for upper gastrointestinal or colorectal cancer. Researchers have addressed the risk of upper gastrointestinal cancer in patients who tested positive in hemoccult test. 61,933 people in a specific region in Denmark...


Read the Article


Sign out of this library

Other Topics